CXCR4 and cancer: Thus, the selective bacterial exotoxin release in CXCR4+ HNSCC cells activate caspase-3/GSDME switch from apoptosis to pyroptosis, as described for different untargeted and targeted drugs in other cancer types [24, 25, 32–34].